Press release
Imatinib Drug Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029)
The incidences of chronic eosinophilic leukemia are expected to increase in the future. Chronic eosinophilic leukemia (CEL) is a disorder in which eosinophil count is greater than 1500 µl in peripheral blood also known as hyper-eosinophilia. It is a rare myeloproliferative neoplasm, overproduction of eosinophils in the bone marrow. Imatinib drug is more beneficial in patients who have leukemia from a genetic mutation. Moreover, the Imatinib drug also supports in improving blood counts and symptoms very fast which makes this drug highly adopted by the targeted patient pool. Imatinib for gastrointestinal stromal tumors (GIST) is also showing a significant share as Imatinib has been the first-line therapy for GIST. The drug targets KIT and PDGFRA (platelet-derived growth factor receptor A) proteins blocking the growth of tumor cells.
To Request a Sample of our Report on Imatinib Drug Market: https://www.omrglobal.com/request-sample/imatinib-drug-market-share
Market Coverage
· The market number available for - 2022-2030
· Base year- 2022
· Forecast period- 2023-2030
· Segment Covered
· Regions Covered- Globally
· Competitive Landscape: Sun Pharmaceutical Industries Ltd., Novartis International AG, and Teva Pharmaceutical Industries Ltd., among others.
Imatinib Drug Market Report by Segment
By Drug Formulation
• Capsules
• Tablets
By Application
• Philadelphia Positive Chronic Myeloid Leukemia
• Myeloproliferative Diseases (MPD)
• Hyper-Eosinophilic Syndrome (HES)
• Myelodysplastic Syndrome (MDS)
• Gastrointestinal Stromal Tumors (GIST)
• Others
A full Report of Imatinib Drug Market is Available at: https://www.omrglobal.com/industry-reports/imatinib-drug-market-share
Imatinib Drug Market by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
Reasons to buy from us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
https://www.somosxbox.com.mx/noticias-urgente/el-mercado-de-cubiertas-moviles-sera-testigo-de-un-crecimiento-asombroso-para-2029/120862/
https://perualdia.net/tasa-de-crecimiento-lento-del-mercado-de-cocinas-modulares-previsto-para-2023-2030/
https://ekz-crosstour.ch/news/der-markt-fuer-insektenschutzmittel-wird-bis-2023-2029-ein-starkes-wachstum-verzeichnen/129165/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Imatinib Drug Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029) here
News-ID: 3204394 • Views: …
More Releases from Orion Market Research
Inspection Management Software Market Increasing Demand, Growth Analysis and Fut …
The global inspection management software Market is anticipated to grow at a CAGR of 12.7 % during the forecast period. Quality control is essential in manufacturing and engineering, automotive, aerospace and defense, healthcare and pharmaceuticals, and oil and gas industries. This involves inspecting parts, components, assemblies, and equipment to ensure that they meet quality standards and regulations. Process optimization involves monitoring and enhancing processes to identify faults and inefficiencies. Additionally, maintenance checks…
Aircraft Synthetic Vision Market 2024 Driving Factors Forecast Research 2031
The global aircraft synthetic vision market is anticipated to grow at a CAGR of 3.2% during the forecast period (2024-2031). With the growing technological advancements and collaboration between market players, the overall aircraft synthetic vision market is also growing. For instance, In November 2023, CubCrafters introduced a thermal infrared imaging system option for Garmin G3X-equipped aircraft. According to the company, the system, developed in collaboration with Hood Tech Aero, can improve flight…
Energy ESO Market Growth Probability, Leading Vendors and Future Scenario By 202 …
Energy ESO market is anticipated to grow at a CAGR of 24.2% during the forecast period (2023-2030). Energy engineering offerings outsourcing (ESO) refers to the strategic practice of entrusting specialized energy engineering tasks and duties to external service providers or organizations. these duties encompass a broad spectrum of activities, which includes, energy audits and assessments, energy-efficient system design and implementation, energy management and optimization, renewable energy integration, and energy sustainability…
Wireless Network Security Market Growth Probability, Leading Vendors and Future …
Wireless network security market is anticipated to grow at a CAGR of 9.1% during the forecast period (2023-2030). The growing adoption of next-generation wireless access points (APs) with improving network connectivity is the key factor supporting the growth of the market globally. Users require more bandwidth than ever before, and many organizations are investing in next-generation wireless access points (APs) to provide increased connectivity. To ensure network security and a…
More Releases for Imatinib
Imatinib Drug Market Report- Business Review, Technology, Top Companies and Tren …
The Imatinib Drug Market research report studies the competitive development of the Imatinib Drug Market, such as agreements, new product launches, expansions, and acquisitions in the market. In addition, Imatinib Drug Market provides a region-wise study of the market, including North America, Asia Pacific, Latin America, Middle East, Africa, and Europe. It helps stakeholders understand market players and analyze the top 25 organizations based on their product footprint, market strength,…
Global Imatinib Drug Market Size | COVID-19 Impact Analysis | Forecast to 2027
The global imatinib drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor that is expected to accelerate the growth of the market includes an increase in the prevalence of cancer and an increase in demand for target drug therapy. For instance, according to National Cancer Institute in 2017, the number of new leukemia cases was 62,130 and the number of mortalities…
Imatinib Drug Market Growth, Size, Share, Industry Report and Forecast 2020-2026
FDA approval of imatinib drug for the treatment of different types of cancers by the major players propelling the growth of the imatinib drug market. For instance, in July 2019, Lupin Ltd. announced the launch of Imatinib Mesylate tablets, 100mg (base) and 400 mg (base). Lupin alliance partner Natco had received approval from the US FDA earlier. Lupin’s Imatinib Mesylate Tablet, 100 mg (base) and 400 mg (base) is the…
Imatinib Drug Market Size, Share, Growth, Industry Analysis, Opportunities and F …
FDA approval of imatinib drug for the treatment of different types of cancers by the major players propelling the growth of the imatinib drug market. For instance, in July 2019, Lupin Ltd. announced the launch of Imatinib Mesylate tablets, 100mg (base) and 400 mg (base). Lupin alliance partner Natco had received approval from the US FDA earlier. Lupin’s Imatinib Mesylate Tablet, 100 mg (base) and 400 mg (base) is the…
Imatinib Drug Market Size, Competitive Analysis, Share, Forecast- 2020-2026
The global imatinib drug market is estimated to grow at a CAGR of around 4% during the forecast period. The major factors contributing to the growth of the market include the rising prevalence of cancer and an increase in awareness programs towards cancer by government and private organizations. Imatinib is a chemotherapy drug that used to slow down or stopping the growth of the cancer cells. This medication is used…
Imatinib Drugs Market to Witness Huge Growth by Key Players: Apotex, Novartis, S …
A new business intelligence report released by HTF MI with title “Global Imatinib Drugs Market Insights, Forecast to 2025” that targets and provides comprehensive market analysis with future prospects to 2023. The analysts of the study have garnered extensive research methodologies and data sources (i.e Secondary & Primary Sources) in order to generate collective and useful information that delivers latest market undercurrents and industry trends.
Request Sample Report @: https://www.htfmarketreport.com/sample-report/1618310-global-imatinib-drugs-market-5
If you…
